Kenneweg John 4

4 · 908 Devices Inc. · Filed Jan 12, 2022

Form 4

Period: 2022-01-10

SVP, Sales & Product Marketing

Transactions

Sale
Common Stock, par value $0.001
2022-01-11$20.15/sh−9,300$187,395→ 0 total
Exercise/Conversion
Stock Option (option to buy)
2022-01-11$0.35/sh−9,300$3,255→ 83,033 total
Exercise: $0.35Exp: 2023-04-18→ Common Stock, par value $0.001 (92,333 underlying)
Exercise/Conversion
Common Stock, par value $0.001
2022-01-10$0.35/sh+700$245→ 700 total
Exercise/Conversion
Common Stock, par value $0.001
2022-01-11$0.35/sh+9,300$3,255→ 9,300 total
Sale
Common Stock, par value $0.001
2022-01-10$20.04/sh−700$14,028→ 0 total
Exercise/Conversion
Stock Option (option to buy)
2022-01-10$0.35/sh−700$245→ 92,333 total
Exercise: $0.35Exp: 2023-04-18→ Common Stock, par value $0.001 (93,033 underlying)

Footnotes (4)

[F1]Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.01 to $20.08, inclusive. The reporting person undertakes to provide to 908 Devices Inc., any security holder of 908 Devices Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
[F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.35, inclusive. The reporting person undertakes to provide to 908 Devices Inc., any security holder of 908 Devices Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
[F4]The shares underlying the option are fully vested and immediately exercisable.

Documents

1 file